103 related articles for article (PubMed ID: 31816158)
1. Volunteering at CerviCusco in Peru.
Pantanowitz L; Pantanowitz J; Escalante EP; Krotish D
Cancer Cytopathol; 2020 Mar; 128(3):155-157. PubMed ID: 31816158
[No Abstract] [Full Text] [Related]
2. Social network characteristics and cervical cancer screening among Quechua women in Andean Peru.
Luque JS; Opoku S; Ferris DG; Guevara Condorhuaman WS
BMC Public Health; 2016 Feb; 16():181. PubMed ID: 26911388
[TBL] [Abstract][Full Text] [Related]
3. The Role of Gynecological Cytology in the Era of Molecular Testing.
Longatto-Filho A
Acta Cytol; 2016; 60(6):499-500. PubMed ID: 27829246
[No Abstract] [Full Text] [Related]
4. ABC3 and LBC - adequate or not?
Duvall E
Cytopathology; 2013 Aug; 24(4):211-5. PubMed ID: 23869916
[No Abstract] [Full Text] [Related]
5. The Impact of Accessible Cervical Cancer Screening in Peru-The Día del Mercado Project.
Ferris DG; Shapiro J; Fowler C; Cutler C; Waller J; Guevara Condorhuaman WS
J Low Genit Tract Dis; 2015 Jul; 19(3):229-33. PubMed ID: 25943865
[TBL] [Abstract][Full Text] [Related]
6. Andrology and accreditation - An opportunity for Cytologists.
Holland L; Maddox A
Cytopathology; 2019 Nov; 30(6):650-652. PubMed ID: 31400165
[No Abstract] [Full Text] [Related]
7. Finding the difficult-to-visualize ventral cervix with the bruno speculum.
Vigliani MB
J Low Genit Tract Dis; 2014 Jan; 18(1):39-40. PubMed ID: 23760144
[No Abstract] [Full Text] [Related]
8. Primary human papillomavirus screening for cervical cancer in the United States-US Food and Drug Administration approval, clinical trials, and where we are today.
Nayar R; Goulart RA; Tiscornia-Wasserman PG; Davey DD
Cancer Cytopathol; 2014 Oct; 122(10):720-9. PubMed ID: 25228434
[No Abstract] [Full Text] [Related]
9. Screening for Cervical Cancer.
Jin J
JAMA; 2018 Aug; 320(7):732. PubMed ID: 30140878
[No Abstract] [Full Text] [Related]
10. The Papanicolaou smear: an insensitive case-finding procedure.
Shulman JJ; Leyton M; Hamilton R
Am J Obstet Gynecol; 1974 Oct; 120(4):446-51. PubMed ID: 4416606
[No Abstract] [Full Text] [Related]
11. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
Printz C
Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
[No Abstract] [Full Text] [Related]
12. Implementation of a real-time reference and calibration grid platform for improved screening - mapping in Pap test slides.
Tsiambas E; Riziotis C
Pathol Int; 2017 Jan; 67(1):24-31. PubMed ID: 27891686
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening in Santiago Atitlán, Guatemala.
Frey MK; Roselli N; Gertz E; Cuc JC; Boyd L; Shirazian T
Int J Gynaecol Obstet; 2016 Oct; 135(1):119. PubMed ID: 27451397
[No Abstract] [Full Text] [Related]
14. Audit of cervical cancer screening and colposcopy attendance in rural South Africa.
Knegt Y
Afr J Reprod Health; 2014 Dec; 18(4):70-8. PubMed ID: 25854095
[TBL] [Abstract][Full Text] [Related]
15. Current status and future trends in cervical cancer screening.
Castle P; Dowdall M
Womens Health (Lond); 2014 Mar; 10(2):129-33. PubMed ID: 24147567
[No Abstract] [Full Text] [Related]
16. A Groundbreaking Work Which Laid the Foundation for Mass Screening in Cervical Cytology in Japan.
Osamura RY
Acta Cytol; 2017; 61(4-5):299-304. PubMed ID: 28693014
[TBL] [Abstract][Full Text] [Related]
17. CytoProcessorTM: A New Cervical Cancer Screening System for Remote Diagnosis.
Crowell EF; Bazin C; Saunier F; Brixtel R; Caillot Y; Lesner B; Toutain M; Ferreri C; Garcia I; Mathieu MC; Vaussanvin J; Depardon J; Renouf A
Acta Cytol; 2019; 63(3):215-223. PubMed ID: 30921788
[TBL] [Abstract][Full Text] [Related]
18. [Current methods for optimization of the cervical cancer diagnosis].
Atanasova D
Akush Ginekol (Sofiia); 2011; 50 Suppl 2():3-7. PubMed ID: 22524130
[No Abstract] [Full Text] [Related]
19. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
20. Swimming upstream: doing less in health care is hard: comment on "No Papanicolaou tests in women younger than 21 years or after hysterectomy for benign disease" and "Cervical cancer screening intervals, 2006 to 2009".
LeFevre ML
JAMA Intern Med; 2013 May; 173(10):856-8. PubMed ID: 23568453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
